Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 22% ± 6% | |
| endothelial cell of lymphatic vessel | 3 studies | 19% ± 4% | |
| myeloid cell | 3 studies | 17% ± 2% | |
| epithelial cell | 3 studies | 34% ± 5% | |
| vein endothelial cell | 3 studies | 25% ± 6% | |
| macrophage | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 7869.43 | 1443 / 1445 | 100% | 78.22 | 183 / 183 |
| intestine | 100% | 6756.46 | 966 / 966 | 100% | 56.07 | 525 / 527 |
| uterus | 100% | 6889.83 | 170 / 170 | 100% | 69.43 | 457 / 459 |
| skin | 100% | 8384.29 | 1809 / 1809 | 99% | 60.88 | 469 / 472 |
| bladder | 100% | 7283.14 | 21 / 21 | 99% | 55.46 | 498 / 504 |
| lung | 100% | 15226.73 | 577 / 578 | 99% | 59.78 | 1143 / 1155 |
| thymus | 100% | 8582.69 | 652 / 653 | 99% | 33.09 | 598 / 605 |
| breast | 100% | 9563.04 | 458 / 459 | 99% | 51.10 | 1103 / 1118 |
| stomach | 99% | 5616.87 | 356 / 359 | 99% | 57.29 | 283 / 286 |
| prostate | 100% | 10172.27 | 244 / 245 | 98% | 39.46 | 494 / 502 |
| ovary | 100% | 6583.09 | 180 / 180 | 98% | 47.31 | 421 / 430 |
| kidney | 100% | 9705.88 | 89 / 89 | 97% | 33.23 | 878 / 901 |
| adrenal gland | 100% | 8582.70 | 258 / 258 | 91% | 26.03 | 210 / 230 |
| pancreas | 88% | 2802.54 | 287 / 328 | 99% | 66.87 | 176 / 178 |
| liver | 95% | 4706.27 | 214 / 226 | 85% | 20.54 | 346 / 406 |
| brain | 29% | 802.00 | 772 / 2642 | 85% | 18.48 | 597 / 705 |
| eye | 0% | 0 | 0 / 0 | 100% | 49.91 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 64.39 | 29 / 29 |
| spleen | 100% | 13589.27 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 87.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 29.24 | 1 / 1 |
| adipose | 100% | 10627.61 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 20372.54 | 925 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 7254.21 | 1324 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 83% | 4799.73 | 668 / 803 | 0% | 0 | 0 / 0 |
| heart | 76% | 3411.76 | 653 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0002281 | Biological process | macrophage activation involved in immune response |
| GO_0061430 | Biological process | bone trabecula morphogenesis |
| GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
| GO_0050727 | Biological process | regulation of inflammatory response |
| GO_0071348 | Biological process | cellular response to interleukin-11 |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0030282 | Biological process | bone mineralization |
| GO_0030316 | Biological process | osteoclast differentiation |
| GO_0071354 | Biological process | cellular response to interleukin-6 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0072675 | Biological process | osteoclast fusion |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005634 | Cellular component | nucleus |
| GO_0031490 | Molecular function | chromatin DNA binding |
| GO_0042393 | Molecular function | histone binding |
| Gene name | SBNO2 |
| Protein name | SBNO2 protein Protein strawberry notch homolog 2 Strawberry notch homolog 2 |
| Synonyms | KIAA0963 |
| Description | FUNCTION: Acts as a transcriptional coregulator, that can have both coactivator and corepressor functions. Inhibits the DCSTAMP-repressive activity of TAL1, hence enhancing the access of the transcription factor MITF to the DC-STAMP promoter in osteoclast. Plays a role in bone homeostasis; required as a positive regulator in TNFSF11//RANKL-mediated osteoclast fusion via a DCSTAMP-dependent pathway. May also be required in the regulation of osteoblast differentiation (By similarity). Involved in the transcriptional corepression of NF-kappaB in macrophages . Plays a role as a regulator in the pro-inflammatory cascade . . |
| Accessions | ENST00000590998.5 ENST00000631778.1 K7ERL2 Q9Y2G9 ENST00000632777.1 ENST00000587655.2 ENST00000587024.5 ENST00000634172.1 K7ENA9 K7ES28 ENST00000590176.5 ENST00000622719.2 [Q9Y2G9-3] ENST00000633604.1 ENST00000612198.3 [Q9Y2G9-1] ENST00000438103.6 [Q9Y2G9-3] ENST00000631948.1 [Q9Y2G9-1] A0JNW0 ENST00000361757.8 [Q9Y2G9-1] |